More about

NYU Langone Health

News
March 17, 2022
11 min read
Save

In age of misinformation, cancer care community seeks new ways to improve communication

In age of misinformation, cancer care community seeks new ways to improve communication

An important component of cancer care is communication with patients and caregivers about their disease.

News
March 10, 2022
2 min read
Save

Venovenous ECMO for severe COVID-19 led to ‘exceptional early survival’ that was sustained

Venovenous ECMO for severe COVID-19 led to ‘exceptional early survival’ that was sustained

Patients with severe COVID-19 who received venovenous extracorporeal membrane oxygenation support had “exceptional early survival” to discharge that was sustained 1 year after cannulation, researchers reported in Annals of Thoracic Surgery.

News
March 04, 2022
1 min read
Save

Nasal exhalation of e-cigarette, hookah aerosols may raise lung inflammation, cancer risk

Nasal exhalation of e-cigarette, hookah aerosols may raise lung inflammation, cancer risk

Many e-cigarette and hookah smokers exhale aerosols through the nose, which may increase risk for lung inflammation and nose, sinus and throat cancers, according to findings published in Tobacco Use Insights.

News
February 23, 2022
3 min read
Save

Patient-reported outcome measure thresholds differed by TSA type, diagnosis

Patient-reported outcome measure thresholds differed by TSA type, diagnosis

TAMPA, Fla. — Researchers who identified differences in clinically relevant results for anatomic and reverse shoulder arthroplasty said understanding these prosthesis- and diagnosis-based differences can aid clinical decision-making.

News
January 26, 2022
2 min read
Save

Removing race-specific coefficient in eGFR equation impacts CKD trial inclusion

Removing race-specific coefficient in eGFR equation impacts CKD trial inclusion

Removing the race-specific coefficient from the equation that determines eGFR results in a “small but potentially important” effect on the inclusion of patients in [chronic kidney disease] trials, according to published data.

News
January 21, 2022
1 min read
Save

ACTIV-4A

ACTIV-4A

P2Y12 inhibitor plus anti-coagulation vs. anticoagulation alone in noncritically ill patients with COVID-19.

News
January 12, 2022
2 min watch
Save

VIDEO: New understanding about fixation of posterior malleolus and syndesmosis fractures

VIDEO: New understanding about fixation of posterior malleolus and syndesmosis fractures

WAIKOLOA, Hawaii — In this video from Orthopedics Today Hawaii, Toni M. McLaurin, MD, spoke about fractures of the posterior malleolus and syndesmosis.

News
December 13, 2021
2 min read
Save

Convalescent plasma may have benefited patients in early days of COVID-19 pandemic

Convalescent plasma may have benefited patients in early days of COVID-19 pandemic

Results from the CONTAIN COVID-19 trial showed that convalescent plasma did not meet prespecified efficacy endpoints in patients hospitalized with COVID-19.

News
December 07, 2021
2 min read
Save

Addition of P2Y12 inhibitor fails to benefit noncritically ill patients with COVID-19

Addition of P2Y12 inhibitor fails to benefit noncritically ill patients with COVID-19

In a cohort of noncritically ill patients with COVID-19, the addition of a P2Y12 inhibitor to anticoagulation did not extend survival or lessen disease severity, according to results of the ACTIV-4a trial.

News
November 30, 2021
2 min read
Save

Study identifies predictors of worsening of atherogenic lipid profile during pandemic

Study identifies predictors of worsening of atherogenic lipid profile during pandemic

Women and racial and ethnic minority groups were more likely to have substantial worsening of atherogenic lipid profiles during COVID-19 stay-at-home orders compared with before the pandemic, researchers reported.

View more